|
NOF has developed the following superior quality activated PEG (SUNBRIGHT series) well-suited for preparing pharmaceuticals and biomedical products. Our SUNBRIGHT series is comprised of extraordinarily purified terminally functional polyalkylene glycols, the most appropriate and versatile DDS formulation materials for PEG-modified drugs.
Drugs, enzymes, phospholipids and other biomaterials can be covalently conjugated with our activated PEGs by various terminal coupling groups, facilitating versatile drug formulation. Our activated PEGs in the SUNBRIGHT series can be used for tethering to or masking colloidal or vesicle surfaces for targeting or in polymeric self-assembled micellar vesicles as a hydrophilic corona.
|
